Drug Type Small molecule drug, Radiopharmaceuticals and diagnostic agent |
Synonyms F-18 HOQ |
Target |
Action modulators, enhancers |
Mechanism APP modulators(Beta amyloid A4 protein modulators), PET imaging(Positron-emission tomography enhancers) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Alzheimer Disease | Preclinical | United States | 01 Jul 2013 |